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The topic of antibiotic resistance has received wide cov-
erage not only in the scientific medical literature but also in
newspapers and other media sources. For most members of
the general population, with the possible exception of
individuals working in the healthcare sector, information
on antibiotic resistance is generally presented in the rela-
tively impersonal form of overall statistics, graphics, per-
centages, and numbers. These numbers have shown an
upward trend in terms of the proportion of resistant bac-
teria. While most clinicians working in the field of infec-
tious diseases, intensive care, and other healthcare
providers in the hospital environment, as well as those
working outside of hospitals, albeit less often, have been
confronted with patients infected by bacteria exhibiting a
broad range of resistances against antibiotics, such expe-
riences are still relatively rare in many countries of the
Western world. Thus, although some physicians have
witnessed lethal outcomes due to essentially non-treatable
infections, the actual problem of antibiotic resistance is
considered by many healthcare providers to be primarily an
epidemiologic and public health problem. As such, they
consider it necessary to curtail inappropriate antibiotic use
and implement infection control measures to prevent the
spread of these pathogens.
Two studies in this issue of Infection demonstrate that the
topic of antibiotic resistance, while still best described using
statistics, is beginning to impact individuals outside of the
hospital environment. In their article, Meyer and colleagues
report that co-infection and co-colonization has increased
steadily over the course of just a few years, as shown in their
study on co-colonization involving the co-presence of
extended-spectrum beta-lactamases (ESBL)-producing
Enterobacteriaceae, vancomycin-resistant Enterococcus
faecium and/or methicillin-resistant Staphylococcus aureus
(MRSA) [1]. In another study involving patients in Cali-
fornia, Abrahamian and colleagues describe the clinical
impact of antibiotic resistance on women with acute
uncomplicated cystitis [2]. These authors report that clinical
cure rates were markedly lower (\50%) if the causative
Enterobacteriaceae were resistant to trimethoprim/sulfa-
methoxazole. This resistance resulted in a reduced health-
related quality of life as a simple consequence of a lower
clinical cure rate, which could clearly be explained by the
presence of resistance to trimethoprim/sulfamethoxazole.
The presence of pathogenic agents resistant to a specific
antibiotic may be considered to be less threatening than the
multi-resistance already confronting physicians at hospi-
tals. However, if the former can have such a negative
impact on quality of life, as reported in the two articles
described in this issue of Infection, what can be expected if
the broadness of resistance widens in the near future?
The description of a negative impact on the quality of
life in the paper of Abrahamian [2] should serve as a fur-
ther warning to all healthcare professionals that the time to
activate and reinforce our fight against the spread of anti-
biotic resistance is NOW.
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